Seattle Genetics Inc. (SGEN) posted a fourth quarter loss of $12.1 million or $0.12 per share, compared to a loss of $30.6 million or $0.38 per share in the prior year quarter.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.23 per share. Analysts' estimates typically exclude special items.
Revenues in the fourth quarter were $21.8 million, compared to $10.1 million in the previous year period. Nine Wall Street analysts expected revenues of $11.71 million.
Looking forward, for the fiscal year 2010, Seattle Genetics expects revenues to be in the range of $95 million to $105 million. Wall Street analysts expect revenues of $47.32 million.
For comments and feedback: editorial@rttnews.com